Aladdin Healthcare Technologies completes Biomedical Knowledge Graph for Commercial use In Drug Development - Proprietary Knowledge Graph 'PharmaKG' released as Software As A Service (SAAS) - PharmaKG makes key findings of potential drug candidates visible - PharmaKG identifies target molecules, pathological causalities and new fields of appl [ … ]

Aladdin Healthcare Technologies signs with leading Market Maker and Broker for OTCQX Listing in the USA - US Listing of Aladdin shares planned to start in late October - The innovative expertise of MCAP matches perfectly Aladdin's needs within the US stock market - Cooperation with US pioneering electronic market maker enhances liquidity of the  [ … ]

Aladdin Healthcare Technologies achieves OTCQX listing in the USA - Aladdin shares enter world's largest technology market - US listing makes Aladdin more appealing for international investors - More availability and better profile of Aladdin shares through OTCQX listing BERLIN/LONDON, August 31, 2020 - Aladdin Healthcare Technologies SE ("Aladdi [ … ]

Aladdin Healthcare Technologies validates its proprietary Deep Learning Algorithms that significantly improve Drug Discovery Performance - Aladdin develops a new deep learning method for drug discovery with superior performance validated on six chemical property and toxicity datasets - Average prediction performance improved by 5-10% compared to  [ … ]

Aladdin Healthcare Technologies becomes a sponsor of University College London's (UCL) Industry Exchange Network (IXN) Programme BERLIN/LONDON, July 28, 2020 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, was appo [ … ]